Summit Therapeutics SMMT Preferred Stock, Shares Issued
Preferred Stock, Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesIssued.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's preferred stock, shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's preferred stock, shares issued?
- Summit Therapeutics (SMMT) reported preferred stock, shares issued of $0 in Q1 2026.